PubMed Clinical Queries
This tool uses predefined filters to help you quickly refine PubMed searches on clinical or disease-specific topics. To use this tool, enter your search terms in the search bar and select filters before searching.
Results for Clinical Studies: Therapy/Broad
5 of 11 results sorted by: Most Recent
See all results in PubMed (11)-
When should we offer antenatal sequencing for urinary tract malformations? A systematic review, cohort study and meta-analysis.
Sonner S, et al. Prenat Diagn. 2024. PMID: 38056891
-
Setmelanotide (Imcivree): CADTH Reimbursement Recommendation: Indication: For weight management in adult and pediatric patients 6 years of age and older with obesity due to Bardet-Biedl syndrome [Internet].
[No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov. Report No.: SR0769. PMID: 38320072 Free Books & Documents. Review.
-
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
Haqq AM, et al. Lancet Diabetes Endocrinol. 2022. PMID: 36356613 Free PMC article. Clinical Trial.
-
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.
Haws RM, et al. Contemp Clin Trials Commun. 2021. PMID: 34013094 Free PMC article.
-
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.
Haws R, et al. Diabetes Obes Metab. 2020. PMID: 32627316 Free PMC article.